Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
J0301098	酒石酸美托洛尔	metoprolol tartrate	Active ingredient	Chemical Drugs	License Renew	2003-08-09	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Certificate Completed-Pending Issued	2004-02-04	view
J0300787	硫酸特布他林	terbutaline sulfate	Active ingredient	Chemical Drugs	License Renew	2003-06-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Approval Completed-Pending Certificated	2003-12-18	view
J0301351	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2004-03-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Certificate Completed-Pending Issued	2004-05-25	view
J0301350	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2004-03-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Certificate Completed-Pending Issued	2004-05-25	view
J0301348	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2004-03-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Approval Completed-Pending Certificated	2004-05-25	view
J0301353	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2004-03-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Certificate Completed-Pending Issued	2004-05-25	view
J0301349	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2004-03-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Certificate Completed-Pending Issued	2004-05-25	view
J0301352	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	Supplementary Application	2004-03-12	AstraZeneca Sverige AB	AstraZeneca Sverige AB	Approval Completed-Pending Certificated	2004-05-25	view